Cargando…
(18)F-alfatide PET/CT may predict short-term outcome of concurrent chemoradiotherapy in patients with advanced non-small cell lung cancer
PURPOSE: The study aims to investigate the role of (18)F-alfatide positron emission tomography/computed tomography (PET/CT) in predicting the short-term outcome of concurrent chemoradiotherapy (CCRT) in patients with advanced non-small cell lung cancer (NSCLC). METHODS: Eighteen patients with advanc...
Autores principales: | Luan, Xiaohui, Huang, Yong, Gao, Song, Sun, Xiaorong, Wang, Suzhen, Ma, Li, Teng, Xuepeng, Lu, Hong, Yu, Jinming, Yuan, Shuanghu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095164/ https://www.ncbi.nlm.nih.gov/pubmed/27631310 http://dx.doi.org/10.1007/s00259-016-3505-3 |
Ejemplares similares
-
Tumor angiogenesis at baseline identified by (18)F-Alfatide II PET/CT may predict survival among patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy
por: Wei, Yuchun, et al.
Publicado: (2022) -
A Pilot Study of (18)F-Alfatide PET/CT Imaging for Detecting Lymph Node Metastases in Patients with Non-Small Cell Lung Cancer
por: Zhou, Yue, et al.
Publicado: (2017) -
Noninvasive Evaluation of Metabolic Tumor Volume in Lewis Lung Carcinoma Tumor-Bearing C57BL/6 Mice with Micro-PET and the Radiotracers (18)F-Alfatide and (18)F-FDG: A Comparative Analysis
por: Wei, Yu-Chun, et al.
Publicado: (2015) -
Stereotactic Comparison Study of (18)F-Alfatide and (18)F-FDG PET Imaging in an LLC Tumor-Bearing C57BL/6 Mouse Model
por: Wei, Yu-Chun, et al.
Publicado: (2016) -
Comparing the Differential Diagnostic Values of (18)F-Alfatide II PET/CT between Tuberculosis and Lung Cancer Patients
por: Du, Xiaoqing, et al.
Publicado: (2018)